RELATIVE POTENCY OF PROGESTINS USED IN ORAL-CONTRACEPTIVES

[11] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J]. AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) : 707 - 714

[12] Grant E C, 1967, J Obstet Gynaecol Br Commonw, V74, P908

[13] GREENBLATT RB, 1967, MEDICAL SCIENCE PHIL, V18, P37

[14] Kay C R, 1980, J R Coll Gen Pract, V30, P8

[15] KAY CR, 1982, AM J OBSTET GYNECOL, V142, P762

[16] PROGESTOGENS AND CARDIOVASCULAR REACTIONS ASSOCIATED WITH ORAL-CONTRACEPTIVES AND A COMPARISON OF THE SAFETY OF 50-MU-G AND 30-MU-G ESTROGEN PREPARATIONS [J]. BRITISH MEDICAL JOURNAL, 1980, 280 (6224) : 1157 - 1161

[17] CLINICAL PHARMACOKINETICS OF ORAL-CONTRACEPTIVE STEROIDS [J]. CLINICAL PHARMACOKINETICS, 1983, 8 (02) : 95 - 136

[18] PIKE MC, 1983, LANCET, V2, P926

[19] POWELL MG, 1984, OBSTET GYNECOL, V63, P764

[20] COMPARATIVE METABOLISM OF 17ALPHA-ETHYNYL STEROIDS USED IN ORAL-CONTRACEPTIVES [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1977, 3 (1-2): : 139 - 166

[11] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J]. AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) : 707 - 714

[12] Grant E C, 1967, J Obstet Gynaecol Br Commonw, V74, P908

[13] GREENBLATT RB, 1967, MEDICAL SCIENCE PHIL, V18, P37

[14] Kay C R, 1980, J R Coll Gen Pract, V30, P8

[15] KAY CR, 1982, AM J OBSTET GYNECOL, V142, P762

[16] PROGESTOGENS AND CARDIOVASCULAR REACTIONS ASSOCIATED WITH ORAL-CONTRACEPTIVES AND A COMPARISON OF THE SAFETY OF 50-MU-G AND 30-MU-G ESTROGEN PREPARATIONS [J]. BRITISH MEDICAL JOURNAL, 1980, 280 (6224) : 1157 - 1161

[17] CLINICAL PHARMACOKINETICS OF ORAL-CONTRACEPTIVE STEROIDS [J]. CLINICAL PHARMACOKINETICS, 1983, 8 (02) : 95 - 136

[18] PIKE MC, 1983, LANCET, V2, P926

[19] POWELL MG, 1984, OBSTET GYNECOL, V63, P764

[20] COMPARATIVE METABOLISM OF 17ALPHA-ETHYNYL STEROIDS USED IN ORAL-CONTRACEPTIVES [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1977, 3 (1-2): : 139 - 166